Prabhdeep Singh - Sep 16, 2022 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Chief Growth Officer
Signature
/s/ Joseph R. Martin, as Attorney-in-Fact
Stock symbol
CLOV
Transactions as of
Sep 16, 2022
Transactions value $
$0
Form type
4
Date filed
9/20/2022, 04:36 PM
Previous filing
Mar 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +353K +68.02% $0.00 873K Sep 16, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of September 16, 2022, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of September 16, 2022, in each case subject to the continued service of the Reporting Person on each such vesting date.

Remarks:

Exhibit List 24.1- Power of Attorney